Gilead Sciences Inc Xilio Therapeutics, Inc. (XLO) insider trading activity

Gilead Sciences Inc is > 10% Shareholder of Xilio Therapeutics, Inc.. Currently has a direct ownership of 9.11 Million shares of XLO, which is worth approximately $8.83 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 1,759,978 shares (Common Stock) at a price of $1.04 per share, resulting in proceeds of $1,830,377. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.11M

23.96% 3M change

n/a 12M change

Total Value Held $8.83 Million

GILEAD SCIENCES INC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 18 2024	BUY Open market or private purchase	$1,830,377 $1.04 p/Share	1,759,978 Added 16.2%	9,105,451 Common Stock
Apr 02 2024	BUY Open market or private purchase	$368,790 $0.76 p/Share	485,250 Added 6.2%	7,345,473 Common Stock

Also insider at

RCUS

Arcus Biosciences, Inc. Healthcare

> 10% Shareholder

ALVR

Allovir, Inc. Healthcare

> 10% Shareholder

KYTX

Kyverna Therapeutics, Inc.

> 10% Shareholder

ASMB

ASSEMBLY BIOSCIENCES, INC. Healthcare

> 10% Shareholder

GSI